- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Medicare Advantage Premiums Expected to Be Mostly Unchanged in 2016
As enrollment in Medicare Advantage is expected to increase to a new all-time high for the sixth year in a row, CMS announced that Medicare Advantage premiums will remain stable in 2016.
As enrollment in Medicare Advantage (MA) is expected to increase to a new all-time high for the sixth year in a row, CMS announced that MA premiums will remain stable in 2016.
According to new information from CMS, the average MA premium will decrease from $32.91 in 2015 to $32.60 in 2016. Overall, 59% of enrollees will face no premium increase at all.
“Seniors and people with disabilities continue to experience stable premiums in Medicare health and drug plans while benefiting from a transparent and competitive marketplace,” Sean Cavanaugh, CMS deputy administrator and director of the Center for Medicare, said in a statement. “Medicare Advantage and prescription drug plans remain affordable and provide high quality care.”
Since the passage of the Affordable Care Act in 2010, MA premiums are expected to have decreased nearly 10% while enrollment increases by more than 50%. At approximately 17.4 million enrollees, MA represents one-third of the Medicare population.
Nearly two-thirds of MA enrollees are in plans with at least 4 stars for 2016, an indication that beneficiaries are receiving higher quality care—in 2009 just 17% of enrollees were in plans with 4 or more stars.
Trump Administration’s Message to Supreme Court Puts New Wrinkle in Braidwood Case
February 21st 2025The Trump administration argues that HHS Secretary Robert F. Kennedy Jr can overrule the US Preventive Services Task Force to determine the preventive services covered under the Affordable Care Act.
Read More
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen
5 Key Health Care Moments During President Trump's First Month Back in Office
February 21st 2025President Donald J. Trump pushed for significant health care changes during his first month back in office, through executive orders affecting managed care, drug pricing, and clinical trial diversity guidance.
Read More
NSCLC Advancements Offer Hope, but Disparities Persist
February 20th 2025Ioana Bonta, MD, Georgia Cancer Specialists, discusses the evolving state of non-small cell lung cancer (NSCLC) treatments, their impact on patient outcomes, and the need to address ongoing disparities in these populations.
Read More
